PHAT Competitors & Alternatives

Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

PHAT

Main Stock
$8.92
Tradestie Score
52
Market Cap
$871.90M
Revenue Growth
1.0%
Analyst Upside
+162.3%

Top Competitors

229 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OLMA Olema Pharmaceuticals, Inc. Common Stock
$11.33
$757.72M - 46 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$29.59
$748.90M - 58 Compare
TBPH Theravance Biopharma, Inc.
$16.87
$726.21M 7.6 54 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$22.98
$718.62M - 60 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$32.10
$715.25M - 46 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$139.73
$699.30M - 51 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$6.03
$688.47M - 45 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ARVN Arvinas, Inc
$7.99
$670.30M - 54 Compare

Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)

229 stocks in this industry